Luxbright AB (LUR0) AI Stock Analysis

Luxbright AB

(Frankfurt:LUR0)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Low LeverageMinimal debt reduces financial risk and limits interest-related pressure on operations. The sizable equity cushion also gives Luxbright more capacity to absorb losses or finance development than a highly leveraged balance sheet, although current returns remain weak.

Negative Factors

Persistent UnprofitabilitySustained net and operating losses show that current revenue is not yet sufficient to support the cost base. Continued unprofitability can consume equity, restrict internally funded investment, and make the company dependent on a future improvement in scale or operating efficiency.

Luxbright AB (LUR0) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 1.15M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -0.3
Beta (1Y): -0.50
Revenue Growth: -10.74%
EPS Growth: 1.57%
Country: Germany
Employees: 11
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Devices

Luxbright AB Business Overview & Revenue Model

Company Description

Luxbright AB (publ), a technology-driven enterprise headquartered in Gothenburg, Sweden, specializes in engineering and marketing X-ray tubes, generators, and comprehensive X-ray systems. Established in 2012, the company's primary focus is on providi...

Luxbright AB Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:LUR0 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SE:PAX	60Neutral	SEK 1.54B	-303.85	-1.22%	―	34.05%	-144.96%
SE:BACTI.B	53Neutral	SEK 560.70M	88.89	1.93%	―	-0.51%	―
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
SE:SDOS	45Neutral	SEK 39.91M	-4.57	―	―	-19.44%	-475.48%
SE:SPEC	40Underperform	SEK 20.68M	-0.12	-57.15%	―	―	16.02%
SE:SCIB	30Underperform	SEK 174.38M	-0.78	-303.61%	―	51.21%	42.24%

* Healthcare Sector Average

Performance Comparison

DE:LUR0 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:LUR0	Luxbright AB	0.42	-3.21	-88.54%
SE:PAX	Paxman AB	66.30	-1.10	-1.63%
SE:SCIB	SciBase Holding AB	12.35	-13.24	-51.74%
SE:SPEC	SpectraCure AB	0.01	-0.13	-90.21%
SE:BACTI.B	Bactiguard Holding AB	16.00	-1.00	-5.88%
SE:SDOS	ScandiDos AB	0.56	-0.52	-48.15%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Luxbright AB AI Stock Analysis